CARE Ratings Intrinsic Value
CARERATING Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹907.20 | ₹725.76 - ₹1088.64 | -43.6% | EPS: ₹75.60, Sector P/E: 12x |
| Book Value Method | asset | ₹321.58 | ₹289.42 - ₹353.74 | -80.0% | Book Value/Share: ₹272.00, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹482.37 | ₹434.13 - ₹530.61 | -70.0% | Revenue/Share: ₹198.67, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹643.16 | ₹578.84 - ₹707.48 | -60.0% | EBITDA: ₹324.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹643.16 | ₹514.53 - ₹771.79 | -60.0% | CF Growth: 9.4%, Discount: 15% |
| PEG Ratio Method | growth | ₹483.84 | ₹435.46 - ₹532.22 | -69.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹622.94 | ₹560.65 - ₹685.23 | -61.3% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1216.00 | ₹1094.40 - ₹1337.60 | -24.4% | ROE: 27.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹544.00 | ₹489.60 - ₹598.40 | -66.2% | EPS: ₹75.60, BVPS: ₹272.00 |
Want to compare with current market value? Check CARERATING share price latest .
Valuation Comparison Chart
CARERATING Intrinsic Value Analysis
What is the intrinsic value of CARERATING?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CARE Ratings (CARERATING) is ₹622.94 (median value). With the current market price of ₹1607.90, this represents a -61.3% variance from our estimated fair value.
The valuation range spans from ₹321.58 to ₹1216.00, indicating ₹321.58 - ₹1216.00.
Is CARERATING undervalued or overvalued?
Based on our multi-method analysis, CARE Ratings (CARERATING) appears to be trading above calculated value by approximately 61.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.73 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 27.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 50.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.62x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for CARE Ratings
Additional stock information and data for CARERATING
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹123 Cr | ₹94 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹91 Cr | ₹72 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹82 Cr | ₹82 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹68 Cr | ₹55 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹86 Cr | ₹67 Cr | Positive Free Cash Flow | 8/10 |